BMPR1A and skeletal dysplasia: At the receptor level, FGFR3 facilitates the degradation of Bmpr1a, contributing to the pathogenesis of FGFR3-related skeletal dysplasia.281 The mechanism underlying the selective degradation of Bmpr1a, but not of other BMP receptors, by FGFR3 remains unclear.